Terms: = Thyroid cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
28 results:
1. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
Di X; Wang D; Wu J; Zhu X; Wang Y; Yan J; Wen L; Jiang H; Wen D; Shu B; Zhang S
Gene; 2024 May; 908():148304. PubMed ID: 38387708
[TBL] [Abstract] [Full Text] [Related]
2. CMTM 6 promotes the development of thyroid cancer by inhibiting NIS activity through activating the MAPK signaling pathway.
Chen X; Shen H; Liu H; Tan L; Zhang N
Funct Integr Genomics; 2024 Jan; 24(1):10. PubMed ID: 38221563
[TBL] [Abstract] [Full Text] [Related]
3. N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas.
Gerber TS; Ridder DA; Goeppert B; Brobeil A; Stenzel P; Zimmer S; Jäkel J; Metzig MO; Schwab R; Martin SZ; Kiss A; Bergmann F; Schirmacher P; Galle PR; Lang H; Roth W; Straub BK
Int J Cancer; 2024 May; 154(10):1857-1868. PubMed ID: 38212892
[TBL] [Abstract] [Full Text] [Related]
4. IRS1 promotes thyroid cancer metastasis through emt and PI3K/AKT pathways.
Yu F; Huang D; Kuang Y; Dong J; Han Q; Zhou J; Teng X
Clin Endocrinol (Oxf); 2024 Mar; 100(3):284-293. PubMed ID: 38172081
[TBL] [Abstract] [Full Text] [Related]
5. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma.
Zhong Y; Yu F; Yang L; Wang Y; Liu L; Jia C; Cai H; Yang J; Sheng S; Lv Z; Weng L; Wu B; Zhang X
J Transl Med; 2023 Nov; 21(1):817. PubMed ID: 37974228
[TBL] [Abstract] [Full Text] [Related]
6. Hypoxic papillary thyroid carcinoma cells-secreted exosomes deliver miR-221-3p to normoxic tumor cells to elicit a pro-tumoral effect by regulating the ZFAND5.
Yu F; Deng X; Zhong Y; Guo B; Zhang X; Wu B
Exp Cell Res; 2023 Oct; 431(1):113716. PubMed ID: 37488006
[TBL] [Abstract] [Full Text] [Related]
7. COMMD3-Mediated Endosomal Trafficking of HER2 Inhibits the Progression of Ovarian Carcinoma.
Wang S; Liu Y; Li S; Chen Y; Liu Y; Yan J; Wu J; Li J; Wang L; Xiang R; Shi Y; Qin X; Yang S
Mol Cancer Res; 2023 Mar; 21(3):199-213. PubMed ID: 36445330
[TBL] [Abstract] [Full Text] [Related]
8. Pseudoangiosarcomatous squamous cell carcinoma: a rare subtype of squamous cell carcinoma that needs to be differentiated from angiosarcoma and has a poor prognosis.
Zhan Y; Wan H; Wu L; Ge X; Xie X; Wu L; Cai Y
Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):62-66. PubMed ID: 36227677
[TBL] [Abstract] [Full Text] [Related]
9. Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway.
Luo X; Wang J; Lu J; Wang X; Miao Y; Li Q; Li X; Wang L
Biomed Res Int; 2022; 2022():1874550. PubMed ID: 35757470
[TBL] [Abstract] [Full Text] [Related]
10. ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple cancer Types.
Tan F
Mini Rev Med Chem; 2023; 23(1):88-98. PubMed ID: 35578882
[TBL] [Abstract] [Full Text] [Related]
11. lncRNA ZNF674-AS1 inhibits the migration, invasion and epithelial-mesenchymal transition of thyroid cancer cells by modulating the miR-181a/SOCS4 axis.
Le F; Li HM; Lv QL; Chen JJ; Lin QX; Ji YL; Yi B
Mol Cell Endocrinol; 2022 Mar; 544():111551. PubMed ID: 34990740
[TBL] [Abstract] [Full Text] [Related]
12. Molecular mechanisms of thyroid cancer: A competing endogenous RNA (ceRNA) point of view.
Liu Y; Khan S; Li L; Ten Hagen TLM; Falahati M
Biomed Pharmacother; 2022 Feb; 146():112251. PubMed ID: 34916087
[TBL] [Abstract] [Full Text] [Related]
13. Upregulation of TRIP13 promotes the malignant progression of lung cancer via the emt pathway.
Lu R; Zhou Q; Ju L; Chen L; Wang F; Shao J
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184074
[TBL] [Abstract] [Full Text] [Related]
14. Enhanced LINC01061 Levels as a Serum Biomarker in Gastric cancer and Promotion of Malignant Transformation.
Liang W; Xia B; Yan M; Zhai G; Li M
Oncol Res Treat; 2021; 44(5):242-251. PubMed ID: 33910210
[TBL] [Abstract] [Full Text] [Related]
15. SHCBP1 Promotes Papillary thyroid Carcinoma Carcinogenesis and Progression Through Promoting Formation of Integrin and Collagen and Maintaining Cell Stemness.
Geng H; Guo M; Xu W; Zang X; Wu T; Teng F; Wang Y; Liu X; Wang X; Sun Q; Liang J
Front Endocrinol (Lausanne); 2020; 11():613879. PubMed ID: 33716952
[TBL] [Abstract] [Full Text] [Related]
16. circRNA_0005529 facilitates growth and metastasis of gastric cancer via regulating miR-527/Sp1 axis.
Zhang X; Yang H; Jia Y; Xu Z; Zhang L; Sun M; Fu J
BMC Mol Cell Biol; 2021 Jan; 22(1):6. PubMed ID: 33472586
[TBL] [Abstract] [Full Text] [Related]
17. A pilot study of radiomics signature based on biparametric MRI for preoperative prediction of extrathyroidal extension in papillary thyroid carcinoma.
He J; Zhang H; Wang X; Sun Z; Ge Y; Wang K; Yu C; Deng Z; Feng J; Xu X; Hu S
J Xray Sci Technol; 2021; 29(1):171-183. PubMed ID: 33325448
[TBL] [Abstract] [Full Text] [Related]
18. Gene expression profile in metastatic and non-metastatic parathyroid carcinoma.
Condello V; Cetani F; Denaro M; Torregrossa L; Pardi E; Piaggi P; Borsari S; Poma AM; Muscarella LA; Graziano P; Chiofalo MG; Repaci A; Tallini G; Boi F; Materazzi G; Basolo F; Marcocci C
Endocr Relat Cancer; 2021 Feb; 28(2):111-134. PubMed ID: 33290252
[TBL] [Abstract] [Full Text] [Related]
19. High methionyl-tRNA synthetase expression predicts poor prognosis in patients with breast cancer.
Jin Q; Liu G; Wang B; Li S; Ni K; Wang C; Ren J; Zhang S; Dai Y
J Clin Pathol; 2020 Dec; 73(12):803-812. PubMed ID: 32404475
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.
Wu YC; Li SY; Jia YF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481
[TBL] [Abstract] [Full Text] [Related]
[Next]
